Literature DB >> 24997864

[Proliferative vitreoretinopathy: pathophysiology and clinical diagnosis].

F Rouberol1, C Chiquet2.   

Abstract

Proliferative vitreoretinopathy (PVR) remains one of the most common causes of failed retinal detachment (RD) surgery. Many histological and clinical studies have highlighted the chain of events leading to PVR: cellular migration into the vitreous cavity, cellular differentiation, myofibroblast proliferation and activation, synthesis of extracellular matrix proteins, then contraction of preretinal tissues. The development of PVR can be explained schematically by cellular exposure to growth factors and cytokines (particularly retinal pigment epithelial cells and glial cells), in the context of break-down of the blood-retinal barrier (inflammation, choroidal detachment, iatrogenic effect of cryotherapy and surgery) and of cellular contact with the vitreous. Although the pathophysiology of PVR is now better understood, its severity remains an issue. A systematic search for preoperative PVR risk factors allows the most suitable therapeutic option to be chosen.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cytokines; Décollement de rétine; Facteurs de croissance; Growth factors; Pathophysiology; Physiopathologie; Proliferative vitreoretinopathy; Prolifération vitréo-rétinienne; Retinal detachment

Mesh:

Year:  2014        PMID: 24997864     DOI: 10.1016/j.jfo.2014.04.001

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  12 in total

Review 1.  THE PATHOGENY OF PROLIFERATIVE VITREORETINOPATHY.

Authors:  Danielescu Ciprian
Journal:  Rom J Ophthalmol       Date:  2015 Apr-Jun

2.  A Novel Role of IL13Rα2 in the Pathogenesis of Proliferative Vitreoretinopathy.

Authors:  Hui Qi; Lijun Dong; Dong Fang; Lu Chen; Yun Wang; Ning Fan; Xingxing Mao; Wenyi Wu; Xiaohe Yan; Guoming Zhang; Shaochong Zhang; Hetian Lei
Journal:  Front Med (Lausanne)       Date:  2022-06-13

3.  Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.

Authors:  Ying Wang; Zhigang Yuan; Caiyun You; Jindong Han; Haiyan Li; Zhuhong Zhang; Hua Yan
Journal:  BMC Ophthalmol       Date:  2014-11-25       Impact factor: 2.209

4.  The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy.

Authors:  Rui Zhang; Xin Sun; Bo Niu
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

5.  Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.

Authors:  Dhanesh Amarnani; Arturo Israel Machuca-Parra; Lindsay L Wong; Christina K Marko; James A Stefater; Tomasz P Stryjewski; Dean Eliott; Joseph F Arboleda-Velasquez; Leo A Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

6.  Autophagy resists EMT process to maintain retinal pigment epithelium homeostasis.

Authors:  Hao Feng; Xin Zhao; Qiqiang Guo; Yanling Feng; Mengtao Ma; Wendong Guo; Xiang Dong; Chengsi Deng; Chunlu Li; Xiaoyu Song; Shuai Han; Liu Cao
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

Review 7.  Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review.

Authors:  Ying Dai; Chenghua Dai; Tao Sun
Journal:  Int Ophthalmol       Date:  2020-02-26       Impact factor: 2.031

8.  Gremlin mediates the TGF-β-induced induction of profibrogenic genes in human retinal pigment epithelial cells.

Authors:  Dong Qin; Xuemin Jin; Yanrong Jiang
Journal:  Exp Ther Med       Date:  2020-01-21       Impact factor: 2.447

9.  Comparison of SNP Genotypes Related to Proliferative Vitreoretinopathy (PVR) across Slovenian and European Subpopulations.

Authors:  Xhevat Lumi; Mateja M Jelen; Daša Jevšinek Skok; Emanuela Boštjančič; Metka Ravnik-Glavač; Marko Hawlina; Damjan Glavač
Journal:  J Ophthalmol       Date:  2018-05-15       Impact factor: 1.909

10.  Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.

Authors:  Georgios Batsos; Eleni Christodoulou; Georgios Vartholomatos; Petros Galanis; Maria Stefaniotou
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.